Principal component analysis of early alcohol, drug and tobacco use with major depressive disorder in US adults

被引:16
|
作者
Wang, Kesheng [1 ,2 ]
Liu, Ying [1 ]
Ouedraogo, Youssoufou [1 ]
Wang, Nianyang [3 ]
Xie, Xin [4 ]
Xu, Chun [5 ]
Luo, Xingguang [2 ,6 ]
机构
[1] East Tennessee State Univ, Dept Biostat & Epidemiol, Coll Publ Hlth, POB 70259,Lamb Hall, Johnson City, TN 37614 USA
[2] Peking Univ, Beijing HuiLongGuan Hosp, Ctr Biol Psychiat, Beijing 100094, Peoples R China
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA
[4] East Tennessee State Univ, Coll Business & Technol, Dept Econ & Finance, Johnson City, TN 37614 USA
[5] Univ Texas Rio Grande, Dept Hlth & Biomed Sci, Coll Hlth Affairs, Brownsville, TX 78520 USA
[6] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT 06516 USA
关键词
Major depression disorder; Early use; Alcohol; Tobacco; Illicit drug; Principal component analysis; NATIONAL EPIDEMIOLOGIC SURVEY; NICOTINE DEPENDENCE; MENTAL-HEALTH; PSYCHIATRIC-DISORDERS; SMOKING-CESSATION; INCREASED RISK; COMORBIDITY; PREVALENCE; ONSET; ASSOCIATION;
D O I
10.1016/j.jpsychires.2018.02.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Early alcohol, tobacco and drug use prior to 18 years old are comorbid and correlated. This study included 6239 adults with major depressive disorder (MDD) in the past year and 72,010 controls from the combined data of 2013 and 2014 National Survey on Drug Use and Health (NSDUH). To deal with multicollinearity existing among 17 variables related to early alcohol, tobacco and drug use prior to 18 years old, we used principal component analysis (PCA) to infer PC scores and then use weighted multiple logistic regression analyses to estimate the associations of potential factors and PC scores with MDD. The odds ratios (ORs) with 95% confidence intervals (CIs) were estimated. The overall prevalence of MDD was 6.7%. The first four PCs could explain 57% of the total variance. Weighted multiple logistic regression showed that PC1 (a measure of psychotherapeutic drugs and illicit drugs other than marijuana use), PC, (a measure of cocaine and hallucinogens), PC, (a measure of early alcohol, cigarettes, and marijuana use), and PC4 (a measure of cigar, smokeless tobacco use and illicit drugs use) revealed significant associations with MDD (OR = 1.12, 95% CI = 1.08-1.16, OR = 1.08, 95% CI = 1.04-1.12, OR = 1.13, 95% CI = 1.07-1.18, and OR = 1.15, 95% CI = 1.09-1.21, respectively). In conclusion, PCA can be used to reduce the indicators in complex survey data. Early alcohol, tobacco and drug use prior to 18 years old were found to be associated with increased odds of adult MDD.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
  • [1] Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders
    Brook, DW
    Brook, JS
    Zhang, CS
    Cohen, P
    Whiteman, M
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (11) : 1039 - 1044
  • [2] Alcohol, tobacco and non-medical drug use and disorders in older US adults
    Moore, A. A.
    Karno, M. P.
    Grella, C. E.
    Niv, N.
    Warda, U.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (06) : 70A - 70A
  • [3] A Randomized, Controlled, Pilot Study of Acamprosate Added to Escitalopram in Adults With Major Depressive Disorder and Alcohol Use Disorder
    Witte, Janet
    Bentley, Kate
    Evins, Anne Eden
    Clain, Alisabet J.
    Baer, Lee
    Pedrelli, Paola
    Fava, Maurizio
    Mischoulon, David
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 787 - 796
  • [4] Single and dual diagnoses of major depressive disorder and posttraumatic stress disorder predicted by triple comorbid trajectories of tobacco, alcohol, and marijuana use among urban adults
    Lee, Jung Yeon
    Brook, Judith S.
    Finch, Stephen J.
    Kim, Wonkuk
    Brook, David W.
    SUBSTANCE ABUSE, 2019, 40 (02) : 221 - 228
  • [5] Structure of major depressive disorder in adolescents and adults in the US general population
    Lamers, Femke
    Burstein, Marcy
    He, Jian-ping
    Avenevoli, Shelli
    Angst, Jules
    Merikangas, Kathleen R.
    BRITISH JOURNAL OF PSYCHIATRY, 2012, 201 (02) : 143 - 150
  • [6] Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis
    Tang, Victor M.
    Yu, Dengdeng
    Weissman, Cory R.
    Jones, Brett D. M.
    Wang, Guan
    Sloan, Matthew E.
    Blumberger, Daniel M.
    Daskalakis, Zafiris J.
    Le Foll, Bernard
    Voineskos, Daphne
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 339 : 691 - 697
  • [7] REPEATED KETAMINE TREATMENT FOR COMORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Abdallah, C. G.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Jane, J. S.
    Sofuoglu, M.
    Krystal, J. H.
    Petrakis, I. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 97A - 97A
  • [8] Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review
    Fuentes, J. J.
    Mayans, J.
    Guarro, M.
    Canosa, I.
    Mestre-Pinto, J. I.
    Fonseca, F.
    Torrens, M.
    BMC PSYCHIATRY, 2024, 24 (01)
  • [9] NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Levy, L.
    Jane, J. S.
    Krystal, J. H.
    Petrakis, I. L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 236A - 236A
  • [10] Fluoxetine : an update of its use in major depressive disorder in adults
    Gourion, D
    Perrin, E
    Quintin, P
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2004, 30 (04): : 392 - 399